Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Differential Expression of Bipotent Commitment-Related Genes in Multipotent Mesenchymal Stromal Cells at Different O 2 Levels.

Buravkova LB., Ezdakova MI., Andrianova IV., Golikova EA., Andreeva ER.

Laboratory Study, published in Dokl Biochem Biophys (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Dokl Biochem Biophys (2020)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
32483753
DOI
10.1134/S1607672920020052

Abstract (original English)

The transcriptomic profile associated with osteo- and adipogenic differentiation in growth-arrested multipotent mesenchymal stromal cells (MSCs) from human adipose tissue was analyzed in vitro at 20% (standard laboratory) and 5% (tissue-related) O 2 levels. Compared with day 7, at 5% O 2 on day 14 spontaneous upregulation of osteo- (RUNX2, SP7, BGLAP, and SPP1) and adipogenic differentiation (CEBPA, PPARG, and ADIPOQ) genes in MSCs was observed (p < 0.05). Thus, upon expansion under tissue-related O 2 , MSCs demonstrated a bipotent transcriptomic profile, which may contribute to the improvement of their hematopoiesis-supportive function.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisAdiponectinAdipose TissueCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell HypoxiaCore Binding Factor Alpha 1 SubunitGene Expression ProfilingGene Expression Regulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.